These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4050651)

  • 1. Propafenone therapy for ventricular tachycardia in the setting of congestive heart failure.
    Brodsky MA; Allen BJ; Abate D; Henry WL
    Am Heart J; 1985 Oct; 110(4):794-9. PubMed ID: 4050651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propafenone: noninvasive evaluation of efficacy.
    Podrid PJ; Cytryn R; Lown B
    Am J Cardiol; 1984 Nov; 54(9):53D-59D. PubMed ID: 6496369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic and electrophysiologic effects of oral propafenone.
    Prystowsky EN; Heger JJ; Chilson DA; Miles WM; Hubbard J; Zipes DP
    Am J Cardiol; 1984 Nov; 54(9):26D-28D. PubMed ID: 6496366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P; Leclercq JF; Assayag P
    Am J Cardiol; 1984 Nov; 54(9):60D-66D. PubMed ID: 6208770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia.
    Connolly SJ; Kates RE; Lebsack CS; Echt DS; Mason JW; Winkle RA
    Am J Cardiol; 1983 Dec; 52(10):1208-13. PubMed ID: 6359849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propafenone treatment of recurrent ventricular tachycardia: comparison of continuous electrocardiographic recording and electrophysiologic study in predicting drug efficacy.
    Heger JJ; Hubbard J; Zipes DP; Miles WM; Prystowsky EN
    Am J Cardiol; 1984 Nov; 54(9):40D-44D. PubMed ID: 6496368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiologic effects and clinical efficacy of oral propafenone therapy in patients with ventricular tachycardia.
    Chilson DA; Heger JJ; Zipes DP; Browne KF; Prystowsky EN
    J Am Coll Cardiol; 1985 Jun; 5(6):1407-13. PubMed ID: 3889099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation.
    Doherty JU; Waxman HL; Kienzle MG; Cassidy DM; Marchlinski FE; Buxton AE; Josephson ME
    J Am Coll Cardiol; 1984 Aug; 4(2):378-81. PubMed ID: 6736479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propafenone: a new agent for ventricular arrhythmia.
    Podrid PJ; Lown B
    J Am Coll Cardiol; 1984 Jul; 4(1):117-25. PubMed ID: 6376591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggravation of electrically provoked ventricular tachycardia during treatment with propafenone.
    Stavens CS; McGovern B; Garan H; Ruskin JN
    Am Heart J; 1985 Jul; 110(1 Pt 1):24-9. PubMed ID: 4013986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F; Grävinghoff L; Grütte E; Jüngst BK; Liersch R; Nomayo H; Puls I; Rautenburg HW; Schmaltz A; Schumacher G
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):154-7. PubMed ID: 4010670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propafenone for the treatment of refractory complex ventricular ectopic activity.
    Hammill SC; Sorenson PB; Wood DL; Sugrue DD; Osborn MJ; Gersh BJ; Holmes DR
    Mayo Clin Proc; 1986 Feb; 61(2):98-103. PubMed ID: 3945115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and long-term efficacy of oral propafenone in patients with ventricular tachyarrhythmias.
    Budde T; Borggrefe M; Podczeck A; Martinez-Rubio A; Breithardt G
    J Cardiovasc Pharmacol; 1991 Aug; 18(2):254-60. PubMed ID: 1717787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral propafenone in the suppression of chronic stable ventricular arrhythmias.
    Schamroth L; Myburgh DP; Schamroth CL; Scholtz ME; Pincus DR; Kawalsky DL
    Chest; 1985 Apr; 87(4):448-51. PubMed ID: 3884286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and long-term efficacy of propafenone in patients with sustained ventricular tachyarrhythmias: assessment with programmed ventricular stimulation.
    Podczeck A; Frohner K; Hief C; Stix G; Steinbach KK
    Eur Heart J; 1991 Jul; 12(7):796-9. PubMed ID: 1889445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propafenone in the treatment of patients with malignant ventricular tachyarrhythmias.
    Kowey PR; Stohler JL; Friehling TD; Marinchak RA
    Can J Cardiol; 1991 May; 7(4):175-80. PubMed ID: 2070286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propafenone for refractory ventricular arrhythmias: correlation with drug plasma levels during long-term treatment.
    Naccarella F; Bracchetti D; Palmieri M; Marchesini B; Ambrosioni E
    Am J Cardiol; 1984 Nov; 54(8):1008-14. PubMed ID: 6496321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study.
    Naccarella F; Bracchetti D; Palmieri M; Cantelli I; Bertaccini P; Ambrosioni E
    Am Heart J; 1985 Apr; 109(4):833-40. PubMed ID: 3885700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant ventricular tachyarrhythmias in association with propafenone treatment.
    Buss J; Neuss H; Bilgin Y; Schlepper M
    Eur Heart J; 1985 May; 6(5):424-8. PubMed ID: 4043097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.